Trial
NCT02867618
Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Hodgkin Disease
Intervention
Carfilzomib
Why stopped
PI left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-16